Robert H. Eibl

1.7k total citations
26 papers, 1.3k citations indexed

About

Robert H. Eibl is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Robert H. Eibl has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Genetics and 6 papers in Oncology. Recurrent topics in Robert H. Eibl's work include Glioma Diagnosis and Treatment (8 papers), Cancer Genomics and Diagnostics (6 papers) and Virus-based gene therapy research (4 papers). Robert H. Eibl is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Cancer Genomics and Diagnostics (6 papers) and Virus-based gene therapy research (4 papers). Robert H. Eibl collaborates with scholars based in Switzerland, Germany and United States. Robert H. Eibl's co-authors include Hiroko Ohgaki, OD Wiestler, Andreas von Deimling, Markus Schneemann, Bernd R. Seizinger, Richard Y. Chung, David N. Louis, Otmar D. Wiestler, M. Gazi Yaşargil and Paul Kleihues and has published in prestigious journals such as SHILAP Revista de lepidopterología, Physical review. B, Condensed matter and International Journal of Cancer.

In The Last Decade

Robert H. Eibl

26 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert H. Eibl Switzerland 16 699 617 485 371 191 26 1.3k
Sandra H. Bigner United States 11 781 1.1× 660 1.1× 423 0.9× 297 0.8× 268 1.4× 11 1.5k
Márcia Regina Machein Germany 22 926 1.3× 494 0.8× 430 0.9× 632 1.7× 111 0.6× 28 1.6k
Elena I. Fomchenko United States 13 773 1.1× 582 0.9× 605 1.2× 388 1.0× 101 0.5× 23 1.5k
Jens Koopmann United States 14 777 1.1× 535 0.9× 718 1.5× 494 1.3× 135 0.7× 15 1.9k
Charles N. Pegram United States 27 855 1.2× 611 1.0× 830 1.7× 199 0.5× 231 1.2× 46 2.3k
Emmanuelle Huillard France 16 1.2k 1.8× 584 0.9× 326 0.7× 452 1.2× 94 0.5× 20 1.7k
Karisa C. Schreck United States 16 946 1.4× 505 0.8× 418 0.9× 290 0.8× 140 0.7× 55 1.4k
David Tran United States 20 528 0.8× 568 0.9× 485 1.0× 255 0.7× 105 0.5× 39 1.4k
Rodney N. Wiltshire United States 16 823 1.2× 426 0.7× 270 0.6× 307 0.8× 85 0.4× 20 1.3k
Nikki Charles United States 8 940 1.3× 998 1.6× 709 1.5× 647 1.7× 69 0.4× 9 2.2k

Countries citing papers authored by Robert H. Eibl

Since Specialization
Citations

This map shows the geographic impact of Robert H. Eibl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert H. Eibl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert H. Eibl more than expected).

Fields of papers citing papers by Robert H. Eibl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert H. Eibl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert H. Eibl. The network helps show where Robert H. Eibl may publish in the future.

Co-authorship network of co-authors of Robert H. Eibl

This figure shows the co-authorship network connecting the top 25 collaborators of Robert H. Eibl. A scholar is included among the top collaborators of Robert H. Eibl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert H. Eibl. Robert H. Eibl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eibl, Robert H. & Markus Schneemann. (2023). Liquid biopsy and glioblastoma. SHILAP Revista de lepidopterología. 4(1). 28–41. 22 indexed citations
2.
Eibl, Robert H. & Markus Schneemann. (2023). Medulloblastoma: From TP53 Mutations to Molecular Classification and Liquid Biopsy. Biology. 12(2). 267–267. 4 indexed citations
3.
Eibl, Robert H. & Markus Schneemann. (2022). Liquid biopsy for monitoring medulloblastoma. PubMed. 3(3). 263–74. 4 indexed citations
4.
Eibl, Robert H. & Markus Schneemann. (2022). Cell-free DNA as a biomarker in cancer. PubMed. 3(3). 178–98. 13 indexed citations
5.
Eibl, Robert H. & Vincent T. Moy. (2005). Atomic Force Microscopy Measurements of Protein-Ligand Interactions on Living Cells. Methods in molecular biology. 305. 439–449. 19 indexed citations
6.
Eibl, Robert H., et al.. (2005). Measurements of fast fluctuations of viscoelastic properties with the quartz crystal microbalance. The Analyst. 130(11). 1474–1474. 42 indexed citations
7.
Eibl, Robert H. & Martin Benoit. (2004). Molecular resolution of cell adhesion forces. PubMed. 151(3). 128–128. 12 indexed citations
8.
Lamp, Peter, Robert H. Eibl, & G. Buschhorn. (2002). Measurement of electron mobility in liquid and gaseous argon at low electric field strengths and in the critical region. ? 9. 39–45. 1 indexed citations
9.
Eibl, Robert H., Torsten Pietsch, Jürgen Moll, et al.. (1995). Expression of variant CD44 epitopes in human astrocytic brain tumors. Journal of Neuro-Oncology. 26(3). 165–170. 44 indexed citations
10.
Haas, Simone, et al.. (1995). O6‐methylguanine‐DNA methyltransferase activity in breast and brain tumors. International Journal of Cancer. 61(3). 321–326. 77 indexed citations
11.
Kleihues, Paul, Hideaki Ohgaki, Robert H. Eibl, et al.. (1994). Type and Frequency of p53 Mutations in Tumors of the Nervous System and Its Coverings. Recent results in cancer research. 135. 25–31. 15 indexed citations
12.
Wiestler, O. D., Oliver Brüstle, Robert H. Eibl, et al.. (1994). Oncogene Transfer into the Brain. Recent results in cancer research. 135. 55–66. 5 indexed citations
13.
Ohgaki, Hiroko, Robert H. Eibl, Martin Reichel, et al.. (1993). Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system. Molecular Carcinogenesis. 8(2). 74–80. 182 indexed citations
14.
Radner, H., et al.. (1993). Tumor induction by ras and myc oncogenes in fetal and neonatal brain: modulating effects of developmental stage and retroviral dose. Acta Neuropathologica. 86(5). 456–65. 22 indexed citations
15.
Louis, David N., Andreas von Deimling, Richard Y. Chung, et al.. (1993). Comparative Study of p53 Gene and Protein Alterations in Human Astrocytic Tumors. Journal of Neuropathology & Experimental Neurology. 52(1). 31–38. 195 indexed citations
16.
Wiestler, Otmar D., Adriano Aguzzi, Markus Schneemann, et al.. (1992). Oncogene complementation in fetal brain transplants.. PubMed. 52(13). 3760–7. 24 indexed citations
17.
Wiestler, O. D., Oliver Brüstle, Robert H. Eibl, et al.. (1992). A new approach to the molecular basis of neoplastic transformation in the brain. Neuropathology and Applied Neurobiology. 18(5). 443–453. 11 indexed citations
18.
Deimling, Andreas von, Robert H. Eibl, Hiroko Ohgaki, et al.. (1992). p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.. PubMed. 52(10). 2987–90. 244 indexed citations
19.
Wiestler, Otmar D., Oliver Brüstle, Robert H. Eibl, et al.. (1991). Retrovirus‐Mediated Oncogene Transfer into Neural Transplants. Brain Pathology. 2(1). 47–59. 26 indexed citations
20.
Eibl, Robert H., Peter Lamp, & G. Buschhorn. (1990). Measurement of electron mobility in liquid and critical argon at low electric-field strengths. Physical review. B, Condensed matter. 42(7). 4356–4362. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026